ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sosei Heptares to Receive Milestone Payment from Formosa Pharmaceuticals
July 22, 2019osei Group announces Formosa Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for APP13007 to commence a first-in-human (FIH) clinical trial in the United States. -
Sosei Heptares and Genentech enter GPCR target alliance
July 18, 2019Japanese biopharmaceutical group Sosei Heptares has partnered with Roche subsidiary Genentech for the discovery and development of drugs that modulate G protein-coupled receptor (GPCR) targets. -
Sosei Heptares teams up with Genentech for multi-target R&D
July 17, 2019Collaboration aims to discover and develop novel medicines that modulate G protein-coupled receptor (GPCR) targets across a range of diseases -
Sosei Heptares, Genentech Announces Research, License Agreement
July 17, 2019Sosei Group has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and develop novel medicines (new small molecules and/or biologics) that modulate G protein-coupled receptor ( -
Sosei Heptares to get $3m Pfizer milestone payment
June 11, 2019Sosei Heptares has announced that it is to receive a new $3 million milestone payment from its strategic alliance partner Pfizer, as it advances a second candidate from the GPCR collaboration for clinical development.
Pharma Sources Insight January 2025
